Survival in a randomised trial comparing two treatments for ovarian cancer
|futime:||survival or censoring time|
|resid.ds:||residual disease present (1=no,2=yes)|
|ecog.ps:||ECOG performance status (1 is better, see reference)|
Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.